Background
Methods
Inclusion and exclusion criteria
Search strategy
Definitions
Outcomes
Data abstraction
Quality assessment
Assessment of heterogeneity
Statistical analysis
Results
Description of studies
Risk of bias of included studies
Primary outcomes
Trials comparing HFNC versus COT
Trials comparing HFNC versus NIV
Secondary outcomes
Mortality and length of stay
Clinical Outcome | No of Trials (number of patients) | Summary Estimate of Effect (Risk Ratio/Mean Difference with 95% CI) | P-value | I2 (%) |
---|---|---|---|---|
Trials Comparing HFNC vs. COT as an Initial Support Strategy | ||||
ICU mortality | 1(200)a | – | – | – |
Hospital mortality | 2(503) | 0.72(0.42–1.25) | 0.25 | 59% |
ICU length of stay | – | – | – | – |
Hospital length of stay | – | – | – | – |
ED length of stay | 3(531)b | – | – | – |
Trials Comparing HFNC vs. COT After Extubation | ||||
ICU mortality | 3(787) | 0.99(0.47–2.08) | 0.97 | 0% |
Hospital mortality | 2(683) | 0.87(0.47–1.58) | 0.64 | 0% |
ICU length of stay | 4(710) | 3.06(−0.56–6.69) | 0.10 | 0% |
Hospital length of stay | 1(59)a | – | – | – |
ED length of stay | – | – | – | – |
Trials Comparing HFNC vs. NIV as an Initial Support Strategy | ||||
ICU mortality | 1(216)a | – | – | – |
Hospital mortality | – | – | – | – |
ICU length of stay | – | – | – | – |
Hospital length of stay | – | – | – | – |
ED length of stay | 1(204)a | – | – | – |
Trials Comparing HFNC vs. NIV After Extubation | ||||
ICU mortality | 2(1434) | 1.20(0.87–1.85) | 0.40 | 0% |
Hospital mortality | – | – | – | – |
ICU length of stay | 1(604)a | – | – | – |
Hospital length of stay | – | – | – | – |
ED length of stay | – | – | – | – |
Patient comfort
Subgroup analysis
Quality assessment
Quality assessment | No of patients | Effect | Quality | Importance | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No of studies | Design | Limitations | Inconsistency | Indirectness | Imprecision | Other considerations | HFNC | COT/NIV | Relative (95% CI) | Absolute | ||
Intubation rate of HFNC vs. COT as a primary mode | ||||||||||||
5 | randomised trials | seriousa | no serious inconsistency | no serious indirectness | no serious imprecision | reporting biasb | 46/434 (10.6%) | 50/397 (12.6%) | OR 0.74 (0.45 to 1.21) | 30 fewer per 1000 (from 65 fewer to 23 more) | ⊕ ⊕ ΟΟ LOW | CRITICAL |
Reintubation rate of HFNC vs. COT after extubation | ||||||||||||
8 | randomised trials | seriousa | no serious inconsistency | no serious indirectness | no serious imprecision | reporting biasb strong associationc | 63/839 (7.5%) | 123/833 (14.8%) | OR 0.47 (0.29 to 0.76) | 72 fewer per 1000 (from 31 fewer to 100 fewer) | ⊕ ⊕ ⊕Ο MODERATE | CRITICAL |
Intubation rate of HFNC vs. NIV as a primary mode | ||||||||||||
2 | randomised trials | seriousa | no serious inconsistency | no serious indirectness | no serious imprecision | reporting biasd | 47/210 (22.4%) | 68/210 (32.4%) | OR 0.57 (0.36 to 0.92) | 109 fewer per 1000 (from 18 fewer to 173 more) | ⊕ ⊕ ΟΟ LOW | CRITICAL |
Reintubation rate of HFNC vs. NIV after extubation | ||||||||||||
2 | randomised trials | seriousa | no serious inconsistency | no serious indirectness | no serious imprecision | reporting biasd | 118/704 (16.8%) | 123/730 (16.8%) | OR 1.00 (0.76 to 1.32) | 0 fewer per 1000 (from 35 fewer to 43 more) | ⊕ ⊕ ΟΟ LOW | CRITICAL |
Treatment failure of HFNC vs. COT as a primary mode | ||||||||||||
5 | randomised trials | seriousa | no serious inconsistency | no serious indirectness | no serious imprecision | reporting biasb | 58/434 (13.4%) | 71/397 (17.9%) | OR 0.65 (0.43 to 0.98) | 55 fewer per 1000 (from 3 fewer to 93 fewer) | ⊕ ⊕ ΟΟ LOW | CRITICAL |
Treatment failure of HFNC vs. COT after extubation | ||||||||||||
8 | randomised trials | seriousa | serious inconsistencye | no serious indirectness | no serious imprecision | reporting biasbstrong associationc | 108/893 (12.9%) | 192/833 (23%) | OR 0.43 (0.25 to 0.73) | 116 fewer per 1000 (from 51 fewer to 161 fewer) | ⊕ ⊕ ⊕Ο MODERATE | CRITICAL |